A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Phase 1 Study to Compare the Tolerability of OROS Paliperidone (Extended Release) With Immediate-Release (IR) Risperidone in Subjects With Schizophrenia.

Next Previous
Trial Profile

A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Phase 1 Study to Compare the Tolerability of OROS Paliperidone (Extended Release) With Immediate-Release (IR) Risperidone in Subjects With Schizophrenia.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Mar 2010

At a glance

  • Drugs Paliperidone; Risperidone
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Sponsors Janssen Research & Development

    • Most Recent Events

    • 28 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top